# Cellular Mechanisms Underlying Endothelial and Histopathological Alterations Induced by Cerebral Angiography

**Authors:** Zülfikar Özgür Ertuğrul, Mehmet Cudi Tuncer, Mehmet Uğur Karabat

PMC · DOI: 10.3390/jcm15030974 · Journal of Clinical Medicine · 2026-01-25

## TL;DR

This paper reviews how cerebral angiography can damage blood vessels and brain tissue through oxidative stress and inflammation, especially in patients with health conditions like diabetes.

## Contribution

The study systematically evaluates endothelial and histopathological effects of cerebral angiography, highlighting oxidative stress and inflammation as key mechanisms.

## Key findings

- Cerebral angiography induces endothelial and microvascular changes via mechanical and contrast agent effects.
- Iodinated contrast agents increase oxidative stress and activate pro-inflammatory pathways like NF-κB.
- Patients with diabetes, hypertension, or atherosclerosis experience more severe endothelial damage.

## Abstract

Background/Objectives: Cerebral angiography is a cornerstone diagnostic and therapeutic procedure for cerebrovascular diseases; however, its potential effects on vascular integrity and cellular homeostasis remain incompletely elucidated. This systematic review aims to comprehensively evaluate endothelial and histopathological alterations induced by cerebral angiographic procedures, with particular emphasis on oxidative stress, inflammation, endothelial dysfunction, and blood–brain barrier disruption. Methods: This systematic review was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Scopus, and Web of Science databases were systematically searched for studies published between 1981 and 2025 using predefined keywords related to cerebral angiography, endothelial injury, oxidative stress, inflammation, and histopathological changes. A total of 1142 records were identified, and 216 duplicates were removed. Following title and abstract screening, 312 full-text articles were assessed for eligibility, of which 112 were excluded due to irrelevance or insufficient endothelial or histopathological data. Ultimately, 200 studies were included in the qualitative synthesis. The literature identification, screening, and selection process are summarized in the manuscript. The review protocol was not prospectively registered. Results: The included studies demonstrated that cerebral angiographic procedures induce endothelial and microvascular alterations through both mechanical and contrast-mediated mechanisms. Iodinated contrast agents were consistently associated with increased reactive oxygen species production, reduced endothelial nitric oxide bioavailability, mitochondrial dysfunction, and activation of pro-inflammatory signaling pathways, including nuclear factor kappa B (NF-κB). Histopathological findings revealed endothelial swelling, vacuolization, apoptosis, microthrombus formation, inflammatory cell infiltration, and disruption of endothelial junctions, leading to increased vascular permeability and blood–brain barrier impairment. Mechanical factors related to catheter manipulation and high-pressure contrast injection further exacerbated endothelial injury by altering shear stress and promoting leukocyte adhesion. The severity of endothelial damage and inflammatory responses was consistently greater in patients with comorbid conditions such as diabetes mellitus, hypertension, and atherosclerotic disease. Conclusions: Cerebral angiography may induce endothelial dysfunction and histopathological vascular injury predominantly through oxidative and inflammatory mechanisms. Optimization of contrast agent selection, refinement of procedural techniques, and implementation of endothelial-protective strategies may mitigate vascular injury and improve procedural safety. Further translational and clinical studies are warranted to identify biomarkers and protective interventions targeting angiography-induced endothelial damage.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Diseases:** diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** cerebrovascular diseases (MESH:D002561), hypertension (MESH:D006973), mitochondrial dysfunction (MESH:D028361), inflammation (MESH:D007249), vascular injury (MESH:D057772), Endothelial (MESH:D005642), swelling (MESH:D004487), diabetes mellitus (MESH:D003920), atherosclerotic disease (MESH:D050197)
- **Chemicals:** nitric oxide (MESH:D009569), Iodinated contrast agents (-), reactive oxygen species (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12898351/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12898351/full.md

## References

200 references — full list in the complete paper: https://tomesphere.com/paper/PMC12898351/full.md

---
Source: https://tomesphere.com/paper/PMC12898351